Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0440
+0.0040 (10.00%)
Jun 25, 2026, 11:49 AM EST
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $18.4 million as of June 25, 2026. Its market cap has decreased by -25.87% in one year.
Market Cap
18.40M
Enterprise Value
31.57M
Revenue
n/a
Ranking
n/a
PE Ratio
0.07
Stock Price
$0.04
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 18.40M, an increase of 101.27%. That is a compound annual growth rate of 10.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 18.40M | -50.44% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 28.73M |
| EOM Pharmaceuticals Holdings | 24.07M |
| ZIVO Bioscience | 17.93M |
| LianBio | 17.30M |
| Anebulo Pharmaceuticals | 16.11M |
| Finch Therapeutics Group | 14.93M |
| Galera Therapeutics | 14.12M |
| Inhibitor Therapeutics | 13.38M |